Order Article Reprints

Shinohara H, Kobayashi M, Hayashi K, Nogawa D, Asakawa A, Ohata Y, Kubota K, Takahashi H, Yamada M, Tokunaga M, et al. Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+ TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 2022; 23(21):13235. https://doi.org/10.3390/ijms232113235

Shinohara, Hajime, Maki Kobayashi, Kumiko Hayashi, Daichi Nogawa, Ayaka Asakawa, Yae Ohata, Kazuishi Kubota, Hisashi Takahashi, Miyuki Yamada, Masanori Tokunaga, and et al. 2022. "Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+ TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast Cancer" International Journal of Molecular Sciences 23, no. 21: 13235. https://doi.org/10.3390/ijms232113235

Shinohara, H., Kobayashi, M., Hayashi, K., Nogawa, D., Asakawa, A., Ohata, Y., Kubota, K., Takahashi, H., Yamada, M., Tokunaga, M., Kinugasa, Y., Oda, G., Nakagawa, T., Onishi, I., Kinowaki, Y., Kurata, M., Ohashi, K., Kitagawa, M., & Yamamoto, K. (2022). Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+ TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast Cancer. International Journal of Molecular Sciences, 23(21), 13235. https://doi.org/10.3390/ijms232113235